Inventor · disambiguated record
Magali Zundel
Also filed as: ZUNDEL MAGALI · ZUNDEL MAGALI A
5 granted patents·19 pending applications·143 citations·filing 2001–2016
78Inventor score
Files withNOVO NORDISK AS9NOVO NORDISK HEALTHCARE AG9BEHRENS CARSTEN1NOVO NORDISK PHARMACEUTICALS I1NOVOZYMES AS1
Top patents by PatentIndex Score
24 records- 0195US7524813B2Selectively conjugated peptides and methods of making the sameNOVO NORDISK HEALTHCARE AG·Filed 2006·Granted Apr 28, 2009·72 cites·3 claims
- 0292US7411039B2GLP-2 compounds, formulations, and uses thereofNOVO NORDISK AS·Filed 2003·Granted Aug 12, 2008·69 cites·31 claims
- 0380US9018166B2Conjugated FVIII variantsBEHRENS CARSTEN·Filed 2011·Granted Apr 28, 2015·2 cites·9 claims
- 0465US2007105770A1Transglutaminase mediated conjugation of peptidesNOVO NORDISK AS·Filed 2006·Application pending·0 cites
- 0564US2010028939A1Use of Galactose Oxidase for Selective Chemical Conjugation of Protractor Molecules to Proteins of Therapeutic InterestNOVO NORDISK HEALTHCARE AG·Filed 2008·Application pending·0 cites
- 0664US2014274903A1Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interestNOVO NORDISK HEALTHCARE AG·Filed 2014·Application pending·0 cites
- 0763US2009264366A1Transglutaminase Mediated Conjugation of PeptidesNOVO NORDISK HEALTHCARE AG·Filed 2009·Application pending·0 cites
- 0858US2016355859A1Transglutaminase mediated conjugation of peptidesNOVO NORDISK HEALTHCARE AG·Filed 2016·Application pending·0 cites
- 0958US2006198819A1Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interestNOVO NORDISK HEALTHCARE AG·Filed 2006·Application pending·0 cites
- 1057US2009005312A1Novel glp-1 analogues linked to albumin-like agentsNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 1157US2009253166A1Conjugation of PeptidesNOVO NORDISK AS·Filed 2009·Application pending·0 cites
- 1255US2017020992A1Factor VIII Molecules with Reduced VWF BindingNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 1352US2009082254A1Coupling of Polypeptides at the C-TerminusNOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 1451US2007093417A1Novel GLP-1 analogues linked to albumin-like agentsNOVO NORDISK AS·Filed 2006·Application pending·0 cites
- 1550US2014045753A1Coupling of polypeptides at the c-terminusNOVO NORDISK HEALTHCARE AG·Filed 2013·Application pending·0 cites
- 1650US2016251409A1Targeted Delivery of Factor VIII Proteins to PlateletsNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 1747US2010009917A1Modulating Enzymatic Processes by Addition of Diolcontaining SubstancesNOVO NORDISK HEALTHCARE AG·Filed 2008·Application pending·0 cites
- 1844US7091023B2Stereoselective esterase from Aspergillus oryzaeNOVOZYMES AS·Filed 2001·Granted Aug 15, 2006·0 cites·18 claims
- 1942US6743608B2Process for the preparation of substituted 3-phenyl-propanoic acid esters and substituted 3-phenyl-propanoic acidsNOVO NORDISK PHARMACEUTICALS I·Filed 2002·Granted Jun 1, 2004·0 cites·26 claims
- 2042US2003008361A1Process for the preparation of substituted 3-phenyl-propanoic acid esters and substituted 3-phenyl-propanoic acidsFiled 2002·Application pending·0 cites
- 2142US2009105134A1C-Terminally Pegylated Growth HormonesNOVO NORDISK AS·Filed 2006·Application pending·0 cites
- 2241US2008108557A1Modified ProteinsNOVO NORDISK HEALTHCARE AG·Filed 2005·Application pending·0 cites
- 2341US2012093840A1Targeted delivery of factor viii proteins to plateletsOESTERGAARD HENRIK·Filed 2010·Application pending·0 cites
- 2428US2011306551A1Modification of Factor VIIIZUNDEL MAGALI·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Magali Zundel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →